Emerging Implant Technologies

Emerging Implant Technologies (EIT): Company Overview

Founded: 2014

Headquarters: Wurmlingen, Germany

Specialty: Interbody spinal fusion implants using 3D-printed porous titanium

Website (prior to acquisition): www.eit-spine.de

Medtech Incubator Portfolio Companies Involved: OSP Advisors

Core Focus and Innovation

EIT was a pioneer in developing 3D-printed, open-porous titanium implants specifically designed to support spinal fusion procedures. Their proprietary technology was known for:

  • Trabecular titanium lattice structures that mimic cancellous bone and encourage osseointegration.
  • Additive manufacturing (AM) techniques enabling complex, patient-matched designs and optimized biomechanics.
  • EndoLIF® Platform: A line of interbody fusion cages (for ALIF, PLIF, TLIF, and XLIF approaches) made from porous titanium.
  • Patient-Matched Technology (PMT): Custom-tailored implants for specific patient anatomies, leveraging imaging data.

These innovations addressed common issues in spine surgery, such as suboptimal fusion environments, implant subsidence, and poor fit with traditional PEEK cages.

Acquisition by Johnson & Johnson (DePuy Synthes) – 2018

Acquirer: Johnson & Johnson’s orthopedics division, DePuy Synthes

Announced: July 2018

Deal Type: Private acquisition (financial terms not disclosed)

Strategic Rationale

DePuy Synthes acquired EIT to strengthen its position in the growing 3D-printed spinal implant segment and accelerate innovation in interbody fusion. Key drivers of the acquisition included:

  • Access to advanced additive manufacturing capabilities in titanium implants, enabling competitive differentiation from traditional materials like PEEK.
  • Enhanced portfolio: EIT’s EndoLIF® cages complemented DePuy’s existing spine product suite.
  • European innovation pipeline: EIT’s footprint in Germany gave DePuy a base for further development and regulatory engagement in the EU.
  • Customization capability: EIT’s PMT offered patient-specific solutions, aligning with the broader trend toward personalized orthopedics.

Post-Acquisition Integration

EIT’s technologies were integrated into DePuy Synthes’ spine portfolio, with certain products rebranded or absorbed under broader DePuy lines.

The acquisition enabled Johnson & Johnson to scale 3D-printed implant offerings globally, particularly in North America and key EU markets.

Johnson & Johnson emphasized the synergy between EIT’s design philosophies and their long-term digital surgery roadmap, including data-driven surgical planning and robotics.

Industry Impact and Legacy

EIT is considered one of the early movers that:

  1. Validated porous titanium as a superior material for spinal interbodies.
  2. Proved the commercial viability of 3D printing in regulated spinal devices.
  3. Set the stage for other companies (e.g., NuVasive, Globus Medical, and Stryker) to heavily invest in additive manufacturing.

EIT’s acquisition underscored the shift in the spine market toward:

  • Material science-driven innovation
  • Custom implants and surgical precision
  • Convergence of hardware with digital tools

 

Scroll to top